The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3S,7aR,11aR)-9-(4-chlorobenzyl)-3-isopropyloctahydrooxazolo[2,3-j][1,6]naphthyridin-5(6H)-one ID: ALA5171834
PubChem CID: 168270488
Max Phase: Preclinical
Molecular Formula: C20H27ClN2O2
Molecular Weight: 362.90
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)[C@H]1CO[C@]23CCN(Cc4ccc(Cl)cc4)C[C@H]2CCC(=O)N13
Standard InChI: InChI=1S/C20H27ClN2O2/c1-14(2)18-13-25-20-9-10-22(11-15-3-6-17(21)7-4-15)12-16(20)5-8-19(24)23(18)20/h3-4,6-7,14,16,18H,5,8-13H2,1-2H3/t16-,18-,20-/m1/s1
Standard InChI Key: ODUYWULJYRWPSN-YVWKXTFCSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
-1.2444 0.4196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5300 0.8322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1844 0.4196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1844 -0.4053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5300 -0.8178 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2444 -0.4053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5300 1.6572 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.1845 2.0697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8990 1.6571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8989 0.8322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3145 1.9121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3145 0.5773 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7994 1.2448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1845 2.8944 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.5279 2.7088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5300 -1.6425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1842 -2.0549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8986 -1.6427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6103 -2.0545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6103 -2.8795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9004 -3.2912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1842 -2.8832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8987 0.0073 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2.3246 -3.2919 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-2.3246 2.9222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9447 3.2919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 2 1 0
4 3 1 0
5 4 1 0
1 6 1 0
6 5 1 0
2 7 1 6
8 7 1 0
9 8 1 0
10 9 1 0
3 10 1 0
7 11 1 0
2 12 1 0
12 13 1 0
13 11 1 0
8 14 2 0
11 15 1 6
5 16 1 0
16 17 1 0
18 17 2 0
19 18 1 0
20 19 2 0
21 20 1 0
22 21 2 0
17 22 1 0
3 23 1 1
20 24 1 0
15 25 1 0
15 26 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 362.90Molecular Weight (Monoisotopic): 362.1761AlogP: 3.54#Rotatable Bonds: 3Polar Surface Area: 32.78Molecular Species: NEUTRALHBA: 3HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.99CX LogP: 3.95CX LogD: 3.26Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.82Np Likeness Score: -0.31
References 1. Dam S, Tangara S, Hamela C, Hattabi T, Faïon L, Carre P, Antoine R, Herledan A, Leroux F, Piveteau C, Eveque M, Flipo M, Deprez B, Kremer L, Willand N, Villemagne B, Hartkoorn RC.. (2022) Tricyclic SpiroLactams Kill Mycobacteria In Vitro and In Vivo by Inhibiting Type II NADH Dehydrogenases., 65 (24.0): [PMID:36473699 ] [10.1021/acs.jmedchem.2c01493 ]